Lista de obras - Michael Schotsaert - Dominio Público Uruguay

"Host immune response-inspired development of the influenza vaccine"

scientific article published on 20 April 2020

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

artículo científico publicado en 2015

A High-Resolution Look at Influenza Virus Antigenic Drift

artículo científico publicado en 2016

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

scientific article published on 01 May 2019

A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies

article

A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro

artículo científico publicado en 2020

Animal models for COVID-19

scientific article published on 23 September 2020

Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza

artículo científico publicado en 2017

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

artículo científico publicado el 21 de octubre de 2010

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

scientific article published in 2021

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

article

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

artículo científico publicado en 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

scientific article published on 06 July 2020

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

artículo científico publicado en 2020

Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection

artículo científico publicado en 2017

Controlling influenza by cytotoxic T-cells: calling for help from destroyers

artículo científico publicado en 2010

Current status of COVID-19 (pre)clinical vaccine development

scientific article published on 14 July 2020

Defining the risk of SARS-CoV-2 variants on immune protection

artículo científico publicado en 2022

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

scientific article published on 24 July 2020

Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64

article

FACS-Mediated Isolation of Neuronal Cell Populations From Virus-Infected Human Embryonic Stem Cell-Derived Cerebral Organoid Cultures

article

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

artículo científico publicado en 2017

Inactivated influenza virus vaccines: the future of TIV and QIV.

artículo científico

Influenza vaccines: T-cell responses deserve more attention

artículo científico

Influenza vaccines: a moving interdisciplinary field.

artículo científico publicado en 2014

Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination

artículo científico publicado en 2016

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

artículo científico publicado en 2020

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

artículo científico publicado en 2016

M2e-based universal influenza A vaccine

artículo científico publicado en 2009

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

artículo científico publicado en 2013

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

artículo científico publicado en 2012

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses

artículo científico publicado en 2020

Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death.

artículo científico publicado en 2017

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

artículo científico publicado en 2014

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

artículo científico publicado en 2013

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

artículo científico publicado en 2022

Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization

artículo científico publicado en 2020

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

artículo científico publicado en 2020

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device

scientific article published on 06 October 2020

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen

artículo científico publicado en 2015

Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways. ⬇️

artículo científico publicado en 2018

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine

artículo científico publicado en 2008

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

artículo científico publicado en 2020

TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection

scientific article published on 12 September 2019

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models

scientific article published on 01 December 2020

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

artículo científico publicado en 2009

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

artículo científico publicado en 2008

Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain

artículo científico publicado en 2018

Lista de obras de Michael Schotsaert

"Host immune response-inspired development of the influenza vaccine"

A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody

A High-Resolution Look at Influenza Virus Antigenic Drift

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies

A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro

Animal models for COVID-19

Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective ⬇️

COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection

Controlling influenza by cytotoxic T-cells: calling for help from destroyers

Current status of COVID-19 (pre)clinical vaccine development

Defining the risk of SARS-CoV-2 variants on immune protection

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64

FACS-Mediated Isolation of Neuronal Cell Populations From Virus-Infected Human Embryonic Stem Cell-Derived Cerebral Organoid Cultures

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

Inactivated influenza virus vaccines: the future of TIV and QIV.

Influenza vaccines: T-cell responses deserve more attention

Influenza vaccines: a moving interdisciplinary field.

Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

M2e-based universal influenza A vaccine

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses

Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death.

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultra-violet C (UVC) irradiation device

Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen

Spatial-Temporal Lineage Restrictions of Embryonic p63+ Progenitors Establish Distinct Stem Cell Pools in Adult Airways. ⬇️

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine

Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine

TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

Zika Virus Alters DNA Methylation of Neural Genes in an Organoid Model of the Developing Human Brain